Software as a Service (SaaS) based clinical surveillance, safety, quality, and risk solutions company, VigiLanz launched VigiLanz Research to streamline patient identification and help researchers meet enrollment targets.
The VigiLanz Research solution automates the patient identification process to accelerate patient recruitment and help researchers meet time-sensitive enrollment targets. VigiLanz uses aggregate disparate electronic health records (EHR) and documentation data across health systems in a transactional workflow to optimize clinical outcomes.
According to David Goldsteen, CEO at VigiLanz, the solution leverages the company’s clinical surveillance expertise into a system to screen qualified candidates and can potentially help save millions of dollars. He also stated, “Most importantly, it [VigiLanz Research] also connects people with opportunities for life-changing treatments that could help them live longer, healthier lives.”
After VigiLanz’ launch, Sharp HealthCare entered a partnership with VigiLanz to utilize the VigiLanz Research solution in an acute cardiac clinical trial. The trial, according to VigiLanz, had a complex protocol and challenging patient enrollment requirements.
Using VigiLanz Research automated processes and data collected in Sharp’s EHR) stakeholders saw an increased number of patients screened and reduced staff time needed to screen patients by 50%.
DeAnn Cary, Director of Research at the Outcomes Research Institute at Sharp HealthCare stated, “This solution [VigiLanz Research] solved the biggest challenges we had in screening patients for this study – the short enrollment windows. With near real-time updates, we can now identify and enroll subjects who may have otherwise been missed.”
Cary also explained that by utilizing VigiLanz Research Sharp HealthCare improved its team’s efficiency.